Our Blog Melanoma360

Blog - Melanoma360

Featured image for “Life After Loss: Lisa Huntley’s Life Has Come Full Circle”
03/21/2022

Life After Loss: Lisa Huntley’s Life Has Come Full Circle

by Mara Klecker Lisa Huntley remembers walking out of the hospital without her husband, Grant, in 1994 and thinking to…
Blog - Melanoma360
Friends, Family, & Caregivers
Philanthropy
Featured image for “FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
03/19/2022

FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

CONTACT: Samantha Guild President AIM at Melanoma Foundation 916/206-6100 SGuild@AIMatMelanoma.org March 19, 2022 (Richmond, California) Yesterday, Bristol Myers Squibb announced…
Blog - Melanoma360
Breaking News
Featured image for “Building Psychological Resilience in the Face of Hereditary Risk”
03/09/2022

Building Psychological Resilience in the Face of Hereditary Risk

Living with hereditary cancer risk can be extremely stressful for all cancer patients. In this episode, Dr. Karen Hurley shares…
Blog - Melanoma360
Podcast
Featured image for “Conversations About Immunotherapy and Caregiving”
02/09/2022

Conversations About Immunotherapy and Caregiving

In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
Blog - Melanoma360
Podcast
Featured image for “President’s Letter | January 2022”
01/27/2022

President’s Letter | January 2022

From the Desk of Samantha Guild   Happy 2022! I hope this year is joyful and healthy for you and…
Blog - Melanoma360
President's Letter
Featured image for “In Plain English: The Results of DreamSeq”
01/27/2022

In Plain English: The Results of DreamSeq

By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
Blog - Melanoma360
In Plain English
Featured image for “One Survivor Finds Empowerment through Education and Supporting Others”
01/26/2022

One Survivor Finds Empowerment through Education and Supporting Others

By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
Blog - Melanoma360
Survivor Stories
Featured image for “Become a Member of the Supporters Guild”
01/26/2022

Become a Member of the Supporters Guild

“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
Blog - Melanoma360
Philanthropy
Featured image for “FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma”
01/26/2022

FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma

January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
Blog - Melanoma360
Breaking News
Featured image for “Walking to Conquer Melanoma: Mike’s Miracle Workers”
01/26/2022

Walking to Conquer Melanoma: Mike’s Miracle Workers

By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
Blog - Melanoma360
Friends, Family, & Caregivers
Philanthropy
03/21/2022

Life After Loss: Lisa Huntley’s Life Has Come Full Circle

by Mara Klecker Lisa Huntley remembers walking out of the hospital without her husband, Grant, in 1994 and thinking to…
Featured image for “Life After Loss: Lisa Huntley’s Life Has Come Full Circle”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy
03/19/2022

FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma

CONTACT: Samantha Guild President AIM at Melanoma Foundation 916/206-6100 SGuild@AIMatMelanoma.org March 19, 2022 (Richmond, California) Yesterday, Bristol Myers Squibb announced…
Featured image for “FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma”
Blog - Melanoma360
 | 
Breaking News
03/09/2022

Building Psychological Resilience in the Face of Hereditary Risk

Living with hereditary cancer risk can be extremely stressful for all cancer patients. In this episode, Dr. Karen Hurley shares…
Featured image for “Building Psychological Resilience in the Face of Hereditary Risk”
Blog - Melanoma360
 | 
Podcast
02/09/2022

Conversations About Immunotherapy and Caregiving

In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
Featured image for “Conversations About Immunotherapy and Caregiving”
Blog - Melanoma360
 | 
Podcast
01/27/2022

President’s Letter | January 2022

From the Desk of Samantha Guild   Happy 2022! I hope this year is joyful and healthy for you and…
Featured image for “President’s Letter | January 2022”
Blog - Melanoma360
 | 
President's Letter
01/27/2022

In Plain English: The Results of DreamSeq

By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
Featured image for “In Plain English: The Results of DreamSeq”
Blog - Melanoma360
 | 
In Plain English
01/26/2022

One Survivor Finds Empowerment through Education and Supporting Others

By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
Featured image for “One Survivor Finds Empowerment through Education and Supporting Others”
Blog - Melanoma360
 | 
Survivor Stories
01/26/2022

Become a Member of the Supporters Guild

“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
Featured image for “Become a Member of the Supporters Guild”
Blog - Melanoma360
 | 
Philanthropy
01/26/2022

FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma

January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
Featured image for “FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma”
Blog - Melanoma360
 | 
Breaking News
01/26/2022

Walking to Conquer Melanoma: Mike’s Miracle Workers

By Mara Klecker Even when the pandemic forced the KDB Melanoma 5k Walk/Run to go virtual in 2020, Mike’s Miracle…
Featured image for “Walking to Conquer Melanoma: Mike’s Miracle Workers”
Blog - Melanoma360
 | 
Friends, Family, & Caregivers
 | 
Philanthropy